SANOFI (SNY)

Overview Price 37.41 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 5 - STRONG SELL Open Price $0.00 Previous Close $37.41 Daily Range $0.00 - $0.00 52-Week Range $30.98 - $40.75 Volume 0 Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France. Other Resources for SNY Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Bristol-Myers, SNY Win Plavix Damages February 9, 2012 Zacks Blog: The Zacks Analyst Blog Highlights: Western Union, Mylan, Valeant Pharmaceuticals, Sanofi and Pfizer February 9, 2012 Zacks Blog: Mylan Acquires Two Generics February 8, 2012 Zacks Blog: Perrigo Beats EPS, Top Line Solid February 7, 2012 Zacks Blog: Earnings Scorecard: Bristol-Myers February 6, 2012 Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.   Brokerage Analyst Recommendations 6 Brokerage Firms Covering SNY   Strong Buy 3 Buy 0 Hold 3 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 2   SNY Ratings: BUY  SELL  HOLD SNY Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 31 Buy 0 Sell   Top Buy Analysis BUY: SNY Company: SANOFI-AVENTIS SA Points: 3.96 Start Price: $33.16 Start Date: 12/14/2010 5:55 AM cmmtgnmn P&P Score: 16.01 Recs: fastfood=diabetis=insulin=sanofi/novo/lilly Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
zantriocom	0.00	09/14/09	Zantrio.com Stock Picks for September 14, 2009	0
Zacks_Analysts	0.00	02/09/12	Bristol-Myers, SNY Win Plavix Damages - Analyst Blog	0
Zacks_Analysts	0.00	02/08/12	Mylan Acquires Two Generics - Analyst Blog	0
Zacks_Analysts	0.00	02/07/12	Perrigo Beats EPS, Top Line Solid - Analyst Blog	0
Zacks_Analysts	0.00	02/06/12	Earnings Scorecard: Bristol-Myers - Analyst Blog	0
Zacks_Analysts	0.00	01/31/12	Valeant Withdraws ISTA Offer - Analyst Blog	0
Zacks_Analysts	0.00	01/30/12	Watson in an Upbeat Mood - Analyst Blog	0
Zacks_Analysts	0.00	01/27/12	NVS Beats by a Penny, View Guarded - Analyst Blog	0
Zacks_Analysts	0.00	01/26/12	Bristol-Myers Misses on All Fronts - Analyst Blog	0
Zacks_Analysts	0.00	01/25/12	Genzyme and Veracyte Ink Deal - Analyst Blog	0

Pages: [ 1 ]  2   3   4   5   ...  34  >>

Commentary

BUY: SANOFI-AVENTIS SA (SNY) Start Price: $33.16 Points: +3.96 Created: 12/14/2010 fastfood=diabetis=insulin=sanofi/novo/lilly Comments: 0 | Comment cmmtgnmn Recs:

BUY: SANOFI-AVENTIS SA (SNY) Start Price: $36.87 Points: -0.61 Created: 02/01/2012 Comments: 0 | Comment vip Recs:

BUY: SANOFI-AVENTIS SA (SNY) Start Price: $37.17 Points: -5.91 Created: 06/26/2011 Comments: 0 | Comment dmonnie Recs:

BUY: SANOFI-AVENTIS SA (SNY) Start Price: $38.59 Points: -3.87 Created: 05/18/2011 Comments: 0 | Comment rebeldusk Recs:

BUY: SANOFI-AVENTIS SA (SNY) Start Price: $32.71 Points: +4.75 Created: 12/09/2010 Comments: 0 | Comment FINNSET Recs:

BUY: SANOFI-AVENTIS SA (SNY) Start Price: $32.45 Points: -1.66 Created: 05/11/2010 Comments: 0 | Comment harish63 Recs:

BUY: SANOFI-AVENTIS SA (SNY) Start Price: $33.39 Points: +9.80 Created: 06/25/2008 Comments: 0 | Comment laurel Recs:

BUY: SANOFI-AVENTIS SA (SNY) Start Price: $45.94 Points: -10.64 Created: 01/01/2008 Comments: 0 | Comment warren B Recs:

BUY: SANOFI-AVENTIS SA (SNY) Start Price: $44.22 Points: -7.47 Created: 01/01/2008 Comments: 0 | Comment argonpower Recs:

BUY: SANOFI-AVENTIS SA (SNY) Start Price: $40.82 Points: -0.43 Created: 01/01/2008 Comments: 0 | Comment Karsce Recs:

Pages: [ 1 ]  2   3   4  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
vip	99.98	BUY	One to Three Months	02/01/2012	$36.87	$37.41 (+0.68%)	+1.47%	+2.08%	-0.61
dmonnie	0.21	BUY	One to Three Months	06/26/2011	$37.17	$37.41 (+0.68%)	+0.65%	+6.56%	-5.91
rebeldusk	57.69	BUY	One to Three Years	05/18/2011	$38.59	$37.41 (+0.68%)	-3.05%	+0.82%	-3.87
cmmtgnmn	16.01	BUY	Six Months to a Year	12/14/2010	$33.16	$37.41 (+0.68%)	+12.82%	+8.87%	+3.96	view close
FINNSET		BUY	One to Three Months	12/09/2010	$32.71	$37.41 (+0.68%)	+14.38%	+9.63%	+4.75
harish63	0.54	BUY	Three Plus Years	05/11/2010	$32.45	$37.41 (+0.68%)	+15.29%	+16.95%	-1.66
laurel	42.27	BUY	One to Three Months	06/25/2008	$33.39	$37.41 (+0.68%)	+12.05%	+2.25%	+9.80
warren B	62.61	BUY	Six Months to a Year	01/01/2008	$45.94	$37.41 (+0.68%)	-18.56%	-7.92%	-10.64
argonpower	74.36	BUY	Six Months to a Year	01/01/2008	$44.22	$37.41 (+0.68%)	-15.39%	-7.92%	-7.47
Karsce	78.26	BUY	Six Months to a Year	01/01/2008	$40.82	$37.41 (+0.68%)	-8.35%	-7.92%	-0.43

Pages: [ 1 ]  2   3   4  >>